Literature DB >> 4412492

Coagulation fibrinolysis in sickle-cell disease.

P A Gordon, G R Breeze, J R Mann, J Stuart.   

Abstract

A study of fibrinolytic activity in sickle-cell patients during asymptomatic periods has shown a normal fibrinolytic response to exercise and local heat to the arm. During vasoocclusive crises there was no significant decrease in fibrinolytic activity. These results contrast with earlier reports of decreased fibrinolysis during crisis and a suggestion that fibrinolytic activators might be of value in preventing vasoocclusive episodes. Patients in painful crisis showed a significant rise in fibrinogen concentration and fall in platelet count. The former may contribute to localized vascular sludging by increasing whole-blood viscosity, while the latter probably results from local trapping of platelets in areas of sickling or from subsequent splenic sequestration of damaged platelets. There was no evidence of disseminated, as opposed to localized, intravascular coagulation during crisis.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4412492      PMCID: PMC478160          DOI: 10.1136/jcp.27.6.485

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  INFLUENCE OF FIBRINOGEN ON FLOW PROPERTIES OF ERYTHROCYTE SUSPENSIONS.

Authors:  R E WELLS; T H GAWRONSKI; P J COX; R D PERERA
Journal:  Am J Physiol       Date:  1964-11

2.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

3.  Partial purification and properties of a proteolytic enzyme of human serum.

Authors:  L F REMMERT; P P COHEN
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

4.  Platelet function and survival in sickle cell disease.

Authors:  M J Haut; D H Cowan; J W Harris
Journal:  J Lab Clin Med       Date:  1973-07

5.  Thrombosis in sickle-cell pain crises? Controlled trial of ancrod (Arvin) in young adults.

Authors:  D R Haddock; F I Bonotey-Ahulu; M Janosi; G Ankra-Badu; H A Reid
Journal:  J Trop Med Hyg       Date:  1973-11

6.  The effect of increased fibrinogen content on the viscosity of blood.

Authors:  J P Weaver; A Evans; D N Walder
Journal:  Clin Sci       Date:  1969-02       Impact factor: 6.124

7.  Clinical implications of blood rheology studies.

Authors:  R L Replogle; H J Meiselman; E W Merrill
Journal:  Circulation       Date:  1967-07       Impact factor: 29.690

8.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

9.  Fibrinolytic activity in the clinical crisis of sickle-cell anaemia.

Authors:  A Mahmood; D M Macintosh; A G Shaper
Journal:  Br Med J       Date:  1967-09-09

10.  Effect of moderate exercise on the fibrinolytic system in normal young men and women.

Authors:  J D Cash
Journal:  Br Med J       Date:  1966-08-27
View more
  9 in total

Review 1.  Physiological responses of sickle cell trait carriers during exercise.

Authors:  Philippe Connes; Harvey Reid; Marie-Dominique Hardy-Dessources; Errol Morrison; Olivier Hue
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

2.  Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis.

Authors:  S G Richardson; G R Breeze; J Stuart
Journal:  J Clin Pathol       Date:  1976-10       Impact factor: 3.411

3.  Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.

Authors:  M W Kenny; A J George; J Stuart
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

4.  Management of sickle-cell disease.

Authors:  J Stuart
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

5.  Myocardial infarction in sickle cell disease.

Authors:  C R Martin; C S Johnson; C Cobb; D Tatter; L J Haywood
Journal:  J Natl Med Assoc       Date:  1996-07       Impact factor: 1.798

Review 6.  Myocardial infarction in sickle cell disease.

Authors:  Ishak A Mansi; Fred Rosner
Journal:  J Natl Med Assoc       Date:  2002-06       Impact factor: 1.798

7.  Tissue type plasminogen activator antigen and activity in sickle cell disease.

Authors:  R B Francis
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

8.  A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.

Authors:  George O Adjei; Bamenla Q Goka; Christabel C Enweronu-Laryea; Onike P Rodrigues; Lorna Renner; Abdul M Sulley; Michael Alifrangis; Insaf Khalil; Jorgen A Kurtzhals
Journal:  Malar J       Date:  2014-09-19       Impact factor: 2.979

9.  The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care.

Authors:  Durjoy K Shome; Ahmed Jaradat; Ahmed I Mahozi; Ali S Sinan; Ali Ebrahim; Mohammed Alrahim; Mohammad S Ebraheem; Eman J Mansoor; Kameela S Majed; Sheikh A Azeez Pasha
Journal:  Indian J Crit Care Med       Date:  2018-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.